Building on this foundation, we innovatively established a cystitis model by injecting LPS into the bladders of rats, aiming to explore in detail the underlying mechanism by which KZMK effectively inhibits the triggering of the NLRP3 inflammasome. Here, NLRP3 is linked to cystitis.